“Hope Lies in Dreams”—Ionis’s Stan Crooke and the First Drug for SMA Patients

3:30 PM - 4:30 PM (PDT), Monday, June 13, 2022

Stan Crooke and his Ionis Pharmaceuticals team pioneered antisense drugs and developed the first medicine approved for patients suffering from spinal muscular atrophy (SMA).  The multidecade journey holds lessons for using antisense drugs against other diseases as well as the broader scientific and management practices critical for any company developing treatments for rare diseases that have no medicines yet.

Moderator
photo
Enterprise Editor
Simons Foundation
Speakers
photo
SVP, Rare Disease, External Innovation & Chief Scientific Officer
ACADIA Pharmaceuticals, Inc
photo
CEO and Chairman of the Board
n-Lorem Foundation
photo
Managing Partner
Polaris Partners